Sökning: WFRF:(Jerry D) > Can probiotics modu...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04288naa a2200469 4500 | |
001 | oai:DiVA.org:oru-55041 | |
003 | SwePub | |
008 | 170310s2017 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-550412 URI |
024 | 7 | a https://doi.org/10.1017/S00071145160040372 DOI |
040 | a (SwePub)oru | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a for2 swepub-publicationtype |
100 | 1 | a Bron, Peter A.u NIZO Food Research, Ede, The Netherlands; BE-Basic Foundation, The Netherlands, Delft, The Netherlands4 aut |
245 | 1 0 | a Can probiotics modulate human disease by impacting intestinal barrier function? |
264 | 1 | a Cambridge, United Kingdom :b Cambridge University Press,c 2017 |
338 | a print2 rdacarrier | |
500 | a Funding Agencies:ILSI Europe Probiotic Task ForceFNRSFrench Cancer Research Association (ARC)Fonds de la Recherche Scientifique - FNRS WELBIO-CR-2012S-02RFunds InBev-Baillet LatourERC Starting GrantEuropean Research Council, Starting grant 336452-ENIGMO | |
520 | a Intestinal barrier integrity is a prerequisite for homeostasis of mucosal function, which is balanced to maximise absorptive capacity, while maintaining efficient defensive reactions against chemical and microbial challenges. Evidence is mounting that disruption of epithelial barrier integrity is one of the major aetiological factors associated with several gastrointestinal diseases, including infection by pathogens, obesity and diabetes, necrotising enterocolitis, irritable bowel syndrome and inflammatory bowel disease. The notion that specific probiotic bacterial strains can affect barrier integrity fuelled research in which in vitro cell lines, animal models and clinical trials are used to assess whether probiotics can revert the diseased state back to homeostasis and health. This review catalogues and categorises the lines of evidence available in literature for the role of probiotics in epithelial integrity and, consequently, their beneficial effect for the reduction of gastrointestinal disease symptoms. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Gastroenterologi0 (SwePub)302132 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Gastroenterology and Hepatology0 (SwePub)302132 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskapx Näringslära0 (SwePub)303042 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Health Sciencesx Nutrition and Dietetics0 (SwePub)303042 hsv//eng |
653 | a Probiotics | |
653 | a Gut microbiota | |
653 | a Gut barrier | |
653 | a Immunity | |
653 | a Gastrointestinal disorders | |
700 | 1 | a Kleerebezem, Michielu Host Microbe Interactomics Group, Wageningen University, Wageningen, The Netherlands4 aut |
700 | 1 | a Brummer, Robert-Jan,d 1957-u Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län4 aut0 (Swepub:oru)rnbr |
700 | 1 | a Cani, Patrice D.u Metabolism and Nutrition Research Group, WELBIO – Walloon Excellence in Life Sciences and BIOtechnology, Louvain Drug Research Institute, Université catholique de Louvain, Brussels, Belgium4 aut |
700 | 1 | a Mercenier, Annicku Nutrition and Health Research, Nestlé Research Center, Lausanne, Switzerland4 aut |
700 | 1 | a MacDonald, Thomas T.u Barts and The London school of Medicine and Dentistry, Blizard Institute, Queen Mary University of London, London, UK4 aut |
700 | 1 | a Garcia-Ródenas, Clara Lu Nutrition and Health Research, Nestlé Research Center, Lausanne, Switzerland4 aut |
700 | 1 | a Wells, Jerry M.u Host Microbe Interactomics Group, Wageningen University, Wageningen, The Netherlands4 aut |
710 | 2 | a NIZO Food Research, Ede, The Netherlands; BE-Basic Foundation, The Netherlands, Delft, The Netherlandsb Host Microbe Interactomics Group, Wageningen University, Wageningen, The Netherlands4 org |
773 | 0 | t British Journal of Nutritiond Cambridge, United Kingdom : Cambridge University Pressg 117:1, s. 93-107q 117:1<93-107x 0007-1145x 1475-2662 |
856 | 4 | u https://doi.org/10.1017/S0007114516004037y Fulltext |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-55041 |
856 | 4 8 | u https://doi.org/10.1017/S0007114516004037 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.